Akimichi Morita Selected Research

Pyoderma Gangrenosum

1/2021	Combination immunosuppressant therapy for rapidly progressive pyoderma gangrenosum in a child.
3/2015	[A case of abscess of corpus cavernosum as an early symptom of penile pyodermal gangrenosum: we propose the possibility of a new pathogenic finding].
4/2009	Intractable wounds caused by pyoderma gangrenosum in a patient with critical limb ischemia treated with cyclosporine and adjuvant sympathectomy.
3/2005	Topical tacrolimus therapy for pyoderma gangrenosum.
3/2005	Pyoderma gangrenosum associated with nasal septal perforation, oropharyngeal ulcers and IgA paraproteinemia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Akimichi Morita Research Topics

Disease

43	Psoriasis (Pustulosis Palmaris et Plantaris) 10/2022 - 10/2006
19	Neoplasms (Cancer) 01/2022 - 01/2002
10	Psoriatic Arthritis 02/2021 - 09/2016
8	Melanoma (Melanoma, Malignant) 11/2021 - 08/2008
6	Atopic Dermatitis (Atopic Eczema) 02/2021 - 12/2005
5	Mycosis Fungoides 05/2022 - 06/2013
5	Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous) 03/2022 - 01/2019
5	Skin Diseases (Skin Disease) 02/2022 - 10/2011
5	Pyoderma Gangrenosum 01/2021 - 03/2005
4	Infections 01/2022 - 09/2013
4	Vitiligo 09/2021 - 06/2010
4	Ulcer 01/2021 - 03/2005
4	Systemic Scleroderma (Systemic Sclerosis) 07/2020 - 03/2003
4	Inflammation (Inflammations) 01/2019 - 06/2005
4	Hypersensitivity (Allergy) 12/2014 - 09/2007
3	Merkel Cell Carcinoma 01/2022 - 08/2020
3	Neoplasm Metastasis (Metastasis) 09/2021 - 12/2012
3	Extramammary Paget Disease (Paget Disease, Extramammary) 07/2020 - 05/2018
3	Adult T-Cell Leukemia-Lymphoma (Leukemia Lymphoma, T Cell, Acute, HTLV I Associated) 01/2020 - 05/2013
3	Erythema 02/2009 - 12/2006
2	Interstitial Lung Diseases (Interstitial Lung Disease) 10/2022 - 09/2007
2	Rheumatoid Arthritis 10/2022 - 10/2014
2	Arthritis (Polyarthritis) 10/2022 - 10/2014
2	Lentigo (Lentiginosis) 07/2022 - 11/2021
2	Insulin Resistance 01/2022 - 06/2011
2	Hidradenitis Suppurativa 01/2021 - 09/2019
2	Sacroiliitis 01/2021 - 11/2019
2	Pruritus (Itching) 09/2020 - 06/2014
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 09/2020 - 01/2012
2	Ankylosing Spondylitis 01/2020 - 01/2019
2	Pain (Aches) 09/2019 - 02/2009
2	Head and Neck Neoplasms (Head and Neck Cancer) 01/2019 - 01/2017
2	Bullous Pemphigoid (Pemphigoid) 04/2018 - 02/2017
2	Autoimmune Diseases (Autoimmune Disease) 01/2017 - 10/2014
2	Carcinogenesis 01/2012 - 06/2011

Drug/Important Bio-Agent (IBA)

10	Adalimumab (Humira)FDA Link 01/2022 - 09/2013
10	Monoclonal AntibodiesIBA 06/2021 - 01/2012
8	Ficusin (Psoralen)IBA 02/2022 - 02/2008
8	secukinumabIBA 01/2022 - 12/2014
8	Proteins (Proteins, Gene)FDA Link 05/2020 - 08/2008
7	Pharmaceutical PreparationsIBA 10/2022 - 09/2007
7	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2017
6	Infliximab (Remicade)FDA Link 10/2022 - 09/2013
6	Interleukin-17 (Interleukin 17)IBA 02/2021 - 04/2011
5	Bexarotene (LGD1069)FDA Link 03/2022 - 01/2019
5	Therapeutic UsesIBA 09/2013 - 01/2005
4	AntigensIBA 07/2020 - 01/2002
4	Cyclosporine (Ciclosporin)FDA LinkGeneric 05/2020 - 04/2009
4	CytokinesIBA 10/2018 - 12/2014
3	TYK2 Kinase (Tyrosine Kinase 2)IBA 07/2022 - 10/2018
3	deucravacitinibIBA 07/2022 - 10/2018
3	Biological ProductsIBA 07/2022 - 09/2013
3	Immunoglobulins (Immunoglobulin)IBA 06/2021 - 06/2005
3	Interleukin-22 (IL-22)IBA 09/2020 - 04/2011
3	InterleukinsIBA 05/2020 - 01/2017
3	Cisplatin (Platino)FDA LinkGeneric 04/2020 - 12/2012
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 03/2020 - 11/2004
3	Ustekinumab (CNTO 1275)FDA Link 03/2020 - 09/2013
3	mogamulizumabIBA 01/2020 - 05/2013
3	C-Reactive ProteinIBA 01/2020 - 01/2017
3	SteroidsIBA 08/2018 - 12/2011
3	Immunoglobulin A (IgA)IBA 04/2018 - 03/2005
3	CollagenIBA 02/2008 - 01/2003
2	HLA-B27 Antigen (HLA B27 Antigen)IBA 10/2022 - 01/2022
2	apremilastIBA 07/2022 - 01/2022
2	ixekizumabIBA 02/2022 - 01/2022
2	ChemokinesIBA 01/2022 - 09/2021
2	Immune Checkpoint InhibitorsIBA 01/2022 - 01/2016
2	B7-H1 AntigenIBA 01/2022 - 08/2020
2	HLA Antigens (Human Leukocyte Antigens)IBA 01/2022 - 01/2016
2	spesolimabIBA 12/2021 - 01/2021
2	tildrakizumabIBA 06/2021 - 06/2021
2	Prostaglandins AIBA 06/2021 - 06/2021
2	dupilumabIBA 02/2021 - 09/2020
2	NivolumabIBA 11/2020 - 01/2016
2	Immunoglobulin E (IgE)IBA 09/2020 - 06/2005
2	LigandsIBA 09/2020 - 01/2016
2	Fluorouracil (Carac)FDA LinkGeneric 04/2020 - 05/2018
2	AntibodiesIBA 03/2020 - 04/2018
2	Interleukin-12 (IL 12)IBA 03/2020 - 09/2013
2	Imiquimod (Aldara)FDA LinkGeneric 01/2019 - 12/2018
2	AutoantibodiesIBA 01/2019 - 04/2018
2	Laminin (Merosin)IBA 12/2018 - 04/2018
2	Cholecalciferol (Vitamin D3)FDA Link 08/2018 - 10/2006
2	calcipotriene (calcipotriol)FDA LinkGeneric 08/2018 - 10/2006
2	Messenger RNA (mRNA)IBA 01/2016 - 03/2003
2	Prednisolone (Predate)FDA LinkGeneric 03/2015 - 03/2005
2	titanium dioxide (Titania)FDA Link 01/2012 - 06/2011

Therapy/Procedure

30	Therapeutics 03/2022 - 03/2005
10	Phototherapy (Light Therapy) 05/2022 - 03/2003
6	PUVA Therapy 09/2021 - 02/2008
4	Drug Therapy (Chemotherapy) 04/2020 - 03/2009
3	Photochemotherapy (Photodynamic Therapy) 02/2022 - 03/2011
3	Immunotherapy 01/2022 - 01/2016
2	Biological Therapy 10/2022 - 10/2017
2	Oral Administration 02/2022 - 09/2021
2	Retreatment 03/2019 - 07/2015
2	Transplantation 12/2014 - 07/2014
2	Excimer Lasers 12/2012 - 06/2010
2	Lasers (Laser) 10/2012 - 02/2009